MCHP
MICROCHIP TECHNOLOGY
(NASDAQ: MCHP)
Balfour Capital Group Researched Microchip Technology (MCHP) on December 13th, 2023.
Microchip Technology Incorporated is a leading provider of smart, connected, and secure embedded control and processing solutions. The company’s comprehensive product portfolio includes microcontrollers, analog devices, FPGAs, connectivity products, timing systems, and more. These solutions serve over 100,000 customers across various markets, including industrial, automotive, consumer, aerospace and defense, communications, and computing.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $88.00 on December 13th, 2023.
- Our designated price target stands at $120.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy Microchip Technology (MCHP) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
CAG
CONAGRA BRANDS, INC.
(NYSE: CAG)
Balfour Capital Group Researched Conagra Brands, Inc. (CAG)
on December 18th, 2023.
Conagra Brands is a leading packaged food company operating primarily in the United States. The company offers a diverse portfolio of products across various categories, including frozen meals, snacks, and shelf-stable staples. Some of its well-known brands are Marie Callender’s, Healthy Choice, Banquet, Birds Eye, Duncan Hines, Hunt’s, Slim Jim, and Reddi-wip.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $29.25 on December 18th, 2023.
- Our designated price target stands at $50.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
2025 Q3 EARNING REPORT
A Q3 report evaluates company financials for investors
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
Balfour Capital Group wants to clarify that our recommendation to Buy CONAGRA BRANDS, INC. (CAG) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
PDD
PDD HOLDINGS INC.
(NASDAQ: PDD)
Balfour Capital Group Researched PDD Holdings Inc.
on December 18th, 2023.
PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. PDD Holdings aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from the increased productivity and new opportunities. PDD Holdings has built a network of sourcing, logistics, and fulfillment capabilities, that support its underlying businesses.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $147.50 on December 18th, 2023
- Our designated price target stands at $190.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2024 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy PDD Holdings Inc. is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
DHR
DANAHER CORPORATION
(NYSE: DHR)
Balfour Capital Group Researched Danaher Corporation (DHR) on December 18th, 2023.
Danaher Corporation is a leading global innovator in life sciences and diagnostics, committed to accelerating the power of science and technology to improve human health. The company designs, manufactures, and markets a wide range of professional, medical, industrial, and commercial products and services.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $228.50 on December 18th, 2023.
- Our designated price target stands at $300.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy DANAHER CORPORATION (DHR) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
THC
TENET HEALTHCARE CORPORATION
(NYSE: THC)
Balfour Capital Group Researched Tenet Healthcare Corporation (THC)
on December 18th, 2023.
Tenet Healthcare Corporation is a diversified healthcare services company headquartered in Dallas, Texas. Through its subsidiaries, partnerships, and brands, including United Surgical Partners International (USPI), Tenet operates 65 hospitals and over 450 healthcare facilities. The company also owns Conifer Health Solutions, which provides healthcare support services to health systems and other clients.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $75.75 on December 18th, 2023.
- Our designated price target stands at $160.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy TENET HEALTHCARE CORPORATION is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
UNP
UNION PACIFIC CORPORATION
(NYSE: UNP)
Balfour Capital Group Researched Union Pacific Corporation (UNP)
on December 24th, 2023.
Union Pacific Corporation is a leading railroad operator in the United States, providing freight transportation services across 23 states in the western two-thirds of the country. The company connects with Canada’s rail systems and is the only railroad serving all six major Mexico gateways. Its diversified business mix includes Bulk, Industrial, and Premium business groups, serving approximately 10,000 customers by delivering products in a safe, reliable, fuel-efficient, and environmentally responsible manner
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $243.58 on December 24th, 2023.
- Our designated price target stands at $325.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy UNION PACIFIC CORPORATION (UNP) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
EFX
EQUIFAX INC.
(NYSE: EFX)
Balfour Capital Group Researched Equifax Inc. (EFX)
on January 5th, 2024.
Equifax Inc. is a leading global data, analytics, and technology company that assists businesses and government agencies in making critical decisions with greater confidence. The company leverages a unique blend of differentiated data, analytics, and technology to create insights that empower decision-making processes.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $233.03 on January 5th, 2024.
- Our designated price target stands at $300.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy EQUIFAX INC. (EFX) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
CRWD
CROWDSTRIKE HOLDINGS INC
(NASDAQ: CRWD)
Balfour Capital Group Researched Crowdstrike Holdings Inc on January 5th, 2024.
CrowdStrike is a global cybersecurity company that provides cloud-delivered protection across endpoints, cloud workloads, identity, and data. Its Falcon platform is designed for cybersecurity consolidation and is purpose-built to stop breaches. The platform collects and integrates data from across the enterprise, including endpoints, cloud workloads, identities, and third-party sources.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $248.50 on January 5th, 2024.
- Our designated price target stands at $460.00
- With our $460.00 target met, we are confidently raising our outlook to $589.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q4 EARNING REPORT
A Q4 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy CROWDSTRIKE HOLDINGS INC (CRWD) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
PBF
PBF ENERGY INC.
(NYSE: PBF)
Balfour Capital Group Researched PBF Energy Inc. (PBF)
on January 5th, 2024.
PBF Energy is one of the largest independent petroleum refiners and suppliers of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company operates state-of-the-art refining facilities and has a skilled workforce, enabling it to serve markets across the Northeast, Midwest, Gulf Coast, and West Coast of the U.S., as well as international destinations including Canada and Mexico.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $42.95 on January 5th, 2024.
- Our designated price target stands at $79.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy PBF ENERGY INC. (PBF) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
DVN
DEVON ENERGY CORPORATION
(NYSE: DVN)
Balfour Capital Group Researched Devon Energy Corporation (DVN)
on January 8th, 2024.
Devon Energy Corporation is an American energy company engaged in hydrocarbon exploration and production, focusing on onshore operations in the United States. Its primary areas of operation include the Barnett Shale, STACK formation in Oklahoma, Delaware Basin, Eagle Ford Group, and the Rocky Mountains. As of December 31, 2023, the company reported proved reserves of 1,817 million barrels of oil equivalent, comprising 43% petroleum, 28% natural gas liquids, and 29% natural gas.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $45.94 on January 8th, 2024.
- Our designated price target stands at $80.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Buy DEVON ENERGY CORPORATION (DVN) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
